Shinpoong Pharmaceutical Co.,Ltd (KRX:019170)

South Korea flag South Korea · Delayed Price · Currency is KRW
11,300
-930 (-7.60%)
Mar 3, 2026, 3:30 PM KST
32.94%
Market Cap 592.01B
Revenue (ttm) 231.90B
Net Income (ttm) -3.71B
Shares Out 51.26M
EPS (ttm) -74.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 258,769
Average Volume 183,328
Open 11,810
Previous Close 12,230
Day's Range 11,300 - 11,940
52-Week Range 6,400 - 20,500
Beta 1.35
RSI 27.64
Earnings Date Mar 20, 2026

About KRX:019170

Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; and drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; prescription drugs; woun... [Read more]

Sector Healthcare
Founded 1962
Employees 809
Stock Exchange Korea Stock Exchange
Ticker Symbol 019170
Full Company Profile

Financial Performance

In 2024, KRX:019170's revenue was 221.09 billion, an increase of 10.42% compared to the previous year's 200.23 billion. Losses were -14.82 billion, -74.15% less than in 2023.

Financial Statements

News

There is no news available yet.